ARCHIVES

60 Minutes To Air Segment On The “Deception at Duke”

This article is from The Cancer Letter archive.

Vol. 38 No. 06 | February 10, 2012

Download PDF Visit The Full Archive

Related Articles

IOM Panel Considering NCI Approach To Research In Minorities, Underserved

June 19, 1998

NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ

October 24, 1997

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Search Committee Sends Short List For NCI Director To HHS, White House

April 7, 1995

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

November 15, 2013

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006